References
- Manary MP, Boulding W, Staelin R, Glickman SW. (2013). The patient experience and health outcomes. N Engl J Med 368:1754–3.
- Bertakis KD, Azari R. (2011). Patient-centered care is associated with decreased health care utilization. J Am Board Fam Med 24:229–39. 100170.
- Boulding W, Glickman SW, Manary MP, et al. (2011). Relationship between patient satisfaction with inpatient care and hospital readmission within 30 days. Am J Manag Care 17:41–8.
- Chapman CD, Frey WH, Craft S, et al. (2013). Intranasal treatment of central nervous system dysfunction in humans. Pharm Res 30:2475–84.
- Chen XQ ,Fawcett JR, Rahman YE, et al. (1998). Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis 1:35–44. IOS Press.
- Cheng CH, Chou CJ, Wang PC, et al. (2012). Applying HFMEA to prevent chemotherapy errors. J Med Syst 36:1543–51.
- Chue P. (2006). The relationship between patient satisfaction and treatment outcomes in schizophrenia. J Psychopharmacol 20:38–56.
- Delhaas EM, Huygen FJPM. (2020). Complications associated with intrathecal drug delivery systems. BJA Educ 20:51–7.
- DeRosier J, Stalhandske E, Bagian JP, et al. (2002). Using health care hazard and effect analysis: the VA National Center for Patient Safety’s prospective risk analysis system. J Comm J Qual Improv 28:248–67..
- Dhuria SV, Hanson LR, Frey WH II. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654–73.
- Farrell TW, Tomoaia-Cotisel A, Scammon DL, et al. (2015). Impact of an integrated transition management program in primary care on hospital readmissions. J Healthc Qual 37:81–92.
- Glickman SW, Boulding W, Manary M, et al. (2010). Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circ Cardiovasc Qual Outcomes 3:188–95.
- Gomez D, Martinez JA, Hanson LR, et al. (2012). Intranasal treatment of neurodegenerative diseases and stroke. Front Biosci (Schol Ed) 4:74–89.
- Grennan M, Town RJ. (2020). Regulating innovation with uncertain quality: information, risk, and access in medical devices. Am Econ Rev 110:120–61.
- Kosyakovsky J, Fine JM, Frey WH, Hanson LR. (2021). Mechanisms of intranasal deferoxamine in neurodegenerative and neurovascular disease. Pharmaceuticals 14:95.
- LaVela SL, Gallan A. (2014). Evaluation and measurement of patient experience (2014). Patient Exp J 1:28–36. Available at: https://ssrn.com/abstract=2643249
- Michael J, Barry MD, Susan Edgman-Levitan PA. (2012). Shared decision making — the pinnacle of patient-centered care. N Engl J Med 366:780–1.
- National Research Council. (2001). Crossing the quality chasm: a new health system for the 21st century. Washington (DC): National Academies Press.
- Parsons JE. (2021). Communicating the findings of health technology assessments: considering uncertainty. Med Writing 30:56–9.
- Sherman RE, Anderson SA, Dal Pan GJ, et al. (2016). Real-world evidence - what is it and what can it tell us?. N Engl J Med 375:2293–7.
- Story MF. (2012). FDA perspective in human factor in device development. RAPS Webinar June, 7, 2012.
- Tevis SE ,Kennedy GD, Kent KC. (2015). Is there a relationship between patient satisfaction and favorable surgical outcomes? Adv Surg 49:221–33.
- Wolf A, Olsson LE, Taft C, et al. (2012). Impacts of patient characteristics on hospital care experience in 34,000 Swedish patients. BMC Nurs 11:8.